Randomized treatment arm | NPWT |
---|---|
Study participants with NPWT in the PP population, No. (%) | 157 of 157 (100%) |
Study participants with NPWT and interim CWT period, No | 1* |
Study participants with NPWT and treatment-final CWT period, No. (%) | 63 of 157 (40.1%) |
Start of treatment-final CWT period after NPWT (day), No | 63 |
Mean (SD) | 16.1 (8.3) |
Min–Max | 2–34 |
Study participants with NPWT and treatment-final CWT period starting during inpatient care, No. (%) | 30 of 63 (47.6%) |
Time between start of the treatment-final CWT period after NPWT and hospital discharge (if applicable) (days), No | 30 |
Mean (SD) | 9.8 (10.0) |
Min–Max | 1–41 |
Study participants with NPWT and treatment-final CWT period starting during outpatient care, No. (%) | 33 of 63 (52.4%) |
Total length of treatment-final CWT period after NPWT (days), No | 63 |
Mean (SD) | 20.4 (9.2) |
Min–Max | 3 – 41 |
Length of inpatient treatment-final CWT period after NPWT (days), No | 63+ |
Mean (SD) | 4.4 (6.6) |
Min–Max | 0–25 |
Length of outpatient treatment-final CWT period after NPWT (days), No | 63# |
Mean (SD) | 16.0 (10.6) |
Min–Max | 0–39 |